Apolipoprotein E genotype in senile dementia and Down's syndrome

Area of Science:

• Neuroscience
• Genetics
• Gerontology

Background:

• Apolipoprotein E (APOE) is a key protein in lipid metabolism.
• APOE genotype, particularly the epsilon4 allele, is a known risk factor for Alzheimer's disease.
• The role of APOE in vascular dementia and Down's syndrome requires further investigation.

Purpose of the Study:

• To investigate the frequency of Apolipoprotein E (APOE) genotypes in different dementia populations.
• To assess the utility of APOE genotyping in the differential diagnosis of dementia.
• To examine APOE genotype distribution in healthy elderly controls, Alzheimer's disease, vascular dementia, and Down's syndrome.

Main Methods:

• Genotyping of Apolipoprotein E (APOE) was performed on participants.
• Statistical analyses, including chi-squared and Fisher's exact tests, were used.
• Comparison of APOE genotype frequencies across study groups.

Main Results:

• The epsilon4 allele frequency was significantly higher in Alzheimer's disease and vascular dementia groups compared to controls.
• No significant difference in APOE genotype frequencies was observed between the Down's syndrome group and controls.
• The correlation between APOE genotype and age of onset for Alzheimer's disease was not statistically significant in this cohort.

Conclusions:

• APOE epsilon4 allele is associated with increased risk in both Alzheimer's and vascular dementia.
• APOE genotyping shows limited utility for differentiating between dementia types in this Italian population sample.
• Further research may be needed to clarify the role of APOE in various neurodegenerative conditions.